Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FOSAPREPITANT DIMEGLUMINE Cause Pyrexia? 136 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 136 reports of Pyrexia have been filed in association with FOSAPREPITANT DIMEGLUMINE (Fosaprepitant). This represents 15.3% of all adverse event reports for FOSAPREPITANT DIMEGLUMINE.

136
Reports of Pyrexia with FOSAPREPITANT DIMEGLUMINE
15.3%
of all FOSAPREPITANT DIMEGLUMINE reports
34
Deaths
109
Hospitalizations

How Dangerous Is Pyrexia From FOSAPREPITANT DIMEGLUMINE?

Of the 136 reports, 34 (25.0%) resulted in death, 109 (80.1%) required hospitalization, and 32 (23.5%) were considered life-threatening.

Is Pyrexia Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FOSAPREPITANT DIMEGLUMINE. However, 136 reports have been filed with the FAERS database.

What Other Side Effects Does FOSAPREPITANT DIMEGLUMINE Cause?

Dyspnoea (142) Nausea (130) Infusion related reaction (83) Diarrhoea (80) Vomiting (71) Rash (66) Hypersensitivity (65) Stomatitis (64) Decreased appetite (62) Pain (62)

What Other Drugs Cause Pyrexia?

ADALIMUMAB (12,160) METHOTREXATE (10,158) RITUXIMAB (10,061) PREDNISONE (8,141) ETANERCEPT (7,626) INFLIXIMAB (6,560) ACETAMINOPHEN (6,414) CYCLOPHOSPHAMIDE (6,126) TOCILIZUMAB (5,529) LENALIDOMIDE (5,496)

Which FOSAPREPITANT DIMEGLUMINE Alternatives Have Lower Pyrexia Risk?

FOSAPREPITANT DIMEGLUMINE vs FOSCARBIDOPA\FOSLEVODOPA FOSAPREPITANT DIMEGLUMINE vs FOSCARNET FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN FOSAPREPITANT DIMEGLUMINE vs FOSFOMYCIN TROMETHAMINE FOSAPREPITANT DIMEGLUMINE vs FOSINOPRIL

Related Pages

FOSAPREPITANT DIMEGLUMINE Full Profile All Pyrexia Reports All Drugs Causing Pyrexia FOSAPREPITANT DIMEGLUMINE Demographics